Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Clinical Diagnostics
Pathology Visions 2022 - DeciBio Highlights: Growing Traction for Digital Pathology
Our experts highlight some of the key Digital Pathology trends and themes from the 2022 Pathology Visions conference.
October 31, 2022
Blog Article
Clinical Diagnostics
Pathology Visions 2022 - DeciBio Highlights: Growing Traction for Digital Pathology
Our experts highlight some of the key Digital Pathology trends and themes from the 2022 Pathology Visions conference.
October 31, 2022
Digital Pathology
Precision Medicine
Real-world Data
DeciBio Q&A
Research Tools
10x Genomics’ 2022 Spatial Biology Symposium Review: The New Xenium, Visium and Chromium Study Trifecta with Michael Schnall-Levin, CTO
Check out our latest Q&A with Michael Schnall-Levin, the Chief Technology Officer of 10x Genomics.
October 27, 2022
DeciBio Q&A
Research Tools
10x Genomics’ 2022 Spatial Biology Symposium Review: The New Xenium, Visium and Chromium Study Trifecta with Michael Schnall-Levin, CTO
Check out our latest Q&A with Michael Schnall-Levin, the Chief Technology Officer of 10x Genomics.
October 27, 2022
Spatial Omics
multiomics
DeciBio Q&A
Pharma & Biotech
Targeted autoimmune diseases: DeciBio's Q&A with Isaac Stoner of Octagon Therapeutics
DeciBio recently had the chance to interview Isaac Stoner of Octagon Therapeutics about their new novel targeting approaches for autoimmune diseases.
October 25, 2022
DeciBio Q&A
Pharma & Biotech
Targeted autoimmune diseases: DeciBio's Q&A with Isaac Stoner of Octagon Therapeutics
DeciBio recently had the chance to interview Isaac Stoner of Octagon Therapeutics about their new novel targeting approaches for autoimmune diseases.
October 25, 2022
Biomarkers
DeciBio Q&A
Research Tools
Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics
Our spatial biology experts discuss key drivers of spatial biology utilization across the research continuum. Hear the keys to getting spatial biology to the clinic from an expert spatial operator and thought leader.
October 25, 2022
DeciBio Q&A
Research Tools
Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics
Our spatial biology experts discuss key drivers of spatial biology utilization across the research continuum. Hear the keys to getting spatial biology to the clinic from an expert spatial operator and thought leader.
October 25, 2022
Immuno-Oncology
Proteomics Market
Clinical Diagnostics
Biomarkers
Blog Article
Clinical Diagnostics
New and Established Early Detection Companies Work to Solidify their Standings: This is a Race to Watch
Building off last year's blog, this year we recap updates in the early detection (EDx) landscape that focus on last year’s developments, identify emerging players and technologies, and highlight some geographical considerations.
October 24, 2022
Blog Article
Clinical Diagnostics
New and Established Early Detection Companies Work to Solidify their Standings: This is a Race to Watch
Building off last year's blog, this year we recap updates in the early detection (EDx) landscape that focus on last year’s developments, identify emerging players and technologies, and highlight some geographical considerations.
October 24, 2022
Diagnostics Market
Liquid Biopsy
Biomarkers
DeciBio Q&A
Pharma & Biotech
Off-The-Shelf Cell Therapies: DeciBio's Q&A with Steve Kanner, Ph.D., CSO at Caribou Biosciences
Read as our experts interview with Steve Kanner, CSO at Caribou Biosciences.
October 20, 2022
DeciBio Q&A
Pharma & Biotech
Off-The-Shelf Cell Therapies: DeciBio's Q&A with Steve Kanner, Ph.D., CSO at Caribou Biosciences
Read as our experts interview with Steve Kanner, CSO at Caribou Biosciences.
October 20, 2022
Cell & Gene Tx
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved